Venlafaxine Tablet, Extended Release
Product Images NDC 52427-632

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine (NDC 52427-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almatica Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a table with recommendations for dosage adjustments for a drug called venlafaxine based on different patient characteristics such as hepatic and renal impairment, age, gender and metabolism. It suggests adjusting the dosage of the drug based on the patient's condition.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text appears to be a table displaying interactions between various drugs and substrates in individuals with certain gene variations, along with PK Fold Change and 90% CL Recommendations for Cmax and Auc. The table includes notes regarding dose adjustments, caution in use, and unknown clinical significance.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This text appears to be a drug interaction chart or table. It includes various drugs with their names, such as Atprazotam, Hatoperidol, Cattoine, and Litnium. The table also includes information about Analyte PKFold Change and 90%CiRecommendation, as well as recommendations on dose adjustment and clinical significance. However, the text is partial and does not provide enough context to generate a useful description.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Label (Venlafaxine Label)

Label (Venlafaxine Label)
This is a medication called Venlafaxine which is available in the form of extended-release tablets. It is indicated for use with a prescription and should be sold along with a medication guide to each patient. The tablets, distributed by Almatica Pharma LLC, contain venlafaxine besylate monohydrate equivalent to 112.5mg of venlafaxine. The recommended dosage information can be found in the prescribing information available along with the product. It should be stored in a controlled room temperature environment ranging between 20-25°C or 68°-77°F. The manufacturer is Norwich Pharmaceuticals, Inc. and the package has an NDC code of 52427-632-30. The text also includes batch and expiry info, last revised in June 2022.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.